• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棘层松解性角化不良瘤样恶变:系统回顾。

Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review.

机构信息

Department of Dermatology, National University Hospital, Singapore.

Department of Pathology, National University Hospital, Singapore.

出版信息

Acta Derm Venereol. 2024 Oct 10;104:adv40558. doi: 10.2340/actadv.v104.40558.

DOI:10.2340/actadv.v104.40558
PMID:39387668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11481308/
Abstract

Porokeratosis ptychotropica (PP) is a rare and unusual variant of porokeratosis. There is a dearth of information on the natural history, epidemiology, and optimal treatment options. This study aimed to characterize the worldwide distribution, epidemiology, clinical features, and treatments attempted for all reported cases of porokeratosis ptychotropica. A total of 59 cases of porokeratosis ptychotropica have been reported, with most cases originating from the United States. The median age of patients affected with porokeratosis ptychotropica was 49 years. The most involved body locations are the buttocks and gluteal cleft. The risk of malignant transformation in porokeratosis ptychotropica is approximately 1.7% but there is significant bias in estimating rare occurrences in rare diseases. In conclusion, PP is an important but under-recognized variant of porokeratosis, with a likely low risk of malignant transformation. The best available treatment modality remains uncertain; however, the use of topical lovastatin/cholesterol cream appears promising. Long-term surveillance appears prudent for porokeratosis ptychotropica due to a risk of cancerization.

摘要

播散性浅表性光线性汗孔角化症(PP)是一种罕见且不常见的汗孔角化症变异型。关于其自然病史、流行病学和最佳治疗选择的信息很少。本研究旨在描述所有报道的播散性浅表性光线性汗孔角化症病例的全球分布、流行病学、临床特征和尝试的治疗方法。共报道了 59 例播散性浅表性光线性汗孔角化症,大多数病例来自美国。播散性浅表性光线性汗孔角化症患者的中位年龄为 49 岁。最常见的受累部位是臀部和臀沟。播散性浅表性光线性汗孔角化症恶变的风险约为 1.7%,但在罕见疾病中估计罕见事件存在很大的偏差。总之,PP 是一种重要但认识不足的汗孔角化症变异型,恶变风险可能较低。最佳的治疗方法仍不确定;然而,局部使用洛伐他汀/胆固醇乳膏似乎很有前途。由于有癌变的风险,对播散性浅表性光线性汗孔角化症进行长期监测似乎是谨慎的。

相似文献

1
Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review.棘层松解性角化不良瘤样恶变:系统回顾。
Acta Derm Venereol. 2024 Oct 10;104:adv40558. doi: 10.2340/actadv.v104.40558.
2
An unusual case report of porokeratosis ptychotropica on the buttocks.臀部匐行性回状角化性皮病 1 例罕见病例报告。
Medicine (Baltimore). 2022 Nov 25;101(47):e32074. doi: 10.1097/MD.0000000000032074.
3
Porokeratosis ptychotropica: a rare variant that is commonly misdiagnosed.趋褶性汗孔角化症:一种常被误诊的罕见变异型。
Dermatol Online J. 2020 Jun 15;26(6):13030/qt1vh663z3.
4
Transformation of porokeratosis ptychotropica into invasive squamous cell carcinoma.褶叠性掌跖角化病转变为浸润性鳞状细胞癌。
Int J Dermatol. 2017 Jun;56(6):679-680. doi: 10.1111/ijd.13575. Epub 2017 Feb 15.
5
Porokeratosis ptychotropica: a rare variant of porokeratosis.向心性汗孔角化症:汗孔角化症的一种罕见变异型。
Dermatol Online J. 2014 Jun 15;20(6):13030/qt26d5p9v7.
6
Clinical course of porokeratosis ptychotropica over 7 years in an otherwise healthy child.7 年内健康儿童匐行性回状红斑角化病的临床病程。
Pediatr Dermatol. 2020 Jan;37(1):248-250. doi: 10.1111/pde.14070. Epub 2019 Dec 7.
7
Hyperkeratotic porokeratosis ptychotropica with satellite lesions: a rare presentation of an unusual variant of porokeratosis.伴有卫星状损害的趋褶性角化过度性汗孔角化症:汗孔角化症一种罕见变异型的少见表现。
Acta Dermatovenerol Alp Pannonica Adriat. 2017 Dec;26(4):113-114. doi: 10.15570/actaapa.2017.32.
8
Verrucous porokeratosis of the gluteal cleft (porokeratosis ptychotropica): a rare disorder easily misdiagnosed.臀沟疣状汗孔角化症(向褶性汗孔角化症):一种易被误诊的罕见病症。
J Cutan Pathol. 2010 Jul;37(7):802-7. doi: 10.1111/j.1600-0560.2009.01387.x. Epub 2009 Jul 21.
9
Porokeratosis ptychotropica: a clinically distinct variant of porokeratosis.趋皮性汗孔角化症:汗孔角化症的一种临床独特变体。
J Am Acad Dermatol. 2009 Mar;60(3):501-3. doi: 10.1016/j.jaad.2008.06.038. Epub 2008 Nov 20.
10
Porokeratosis ptychotropica.趋皮性汗孔角化症
An Bras Dermatol. 2016 Sep-Oct;91(5 suppl 1):134-136. doi: 10.1590/abd1806-4841.20164399.

引用本文的文献

1
Expanding the Clinical Spectrum of Porokeratosis Ptychotropica.扩展热带褶烂性汗孔角化症的临床谱。
Cureus. 2025 Jun 10;17(6):e85727. doi: 10.7759/cureus.85727. eCollection 2025 Jun.

本文引用的文献

1
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial.局部洛伐他汀联合胆固醇乳膏与单独使用局部洛伐他汀乳膏治疗播散性浅表性光线性汗孔角化病的疗效和安全性:一项随机临床试验。
JAMA Dermatol. 2023 May 1;159(5):488-495. doi: 10.1001/jamadermatol.2023.0205.
2
A hidden and rare variant of porokeratosis: A case report of porokeratosis ptychotropica and report of the literature.汗孔角化症的一种隐匿且罕见的变异型:褶叠性汗孔角化症病例报告及文献报道
Australas J Dermatol. 2022 Nov;63(4):495-496. doi: 10.1111/ajd.13935. Epub 2022 Oct 17.
3
Porokeratosis is one of the most common genodermatoses and is associated with an increased risk of keratinocyte cancer and melanoma.
掌跖角化病是最常见的遗传性皮肤病之一,与角质形成细胞癌和黑色素瘤的风险增加有关。
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):420-427. doi: 10.1111/jdv.18587. Epub 2022 Oct 1.
4
Bilateral Linear Porokeratosis Treated With Topical Cholesterol 2%/Lovastatin 2.外用2%胆固醇/2%洛伐他汀治疗双侧线状汗孔角化症
Cureus. 2022 Jul 31;14(7):e27540. doi: 10.7759/cureus.27540. eCollection 2022 Jul.
5
Porokeratosis: An enigma beginning to unravel.角化不良症:谜团正在被揭开。
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(3):291-299. doi: 10.25259/IJDVL_806_20.
6
Topical simvastatin-cholesterol for disseminated superficial actinic porokeratosis: An open-label, split-body clinical trial.外用辛伐他汀 - 胆固醇治疗播散性浅表性光化性汗孔角化症:一项开放标签、自身对照临床试验。
Australas J Dermatol. 2021 Aug;62(3):310-313. doi: 10.1111/ajd.13601. Epub 2021 May 24.
7
The Malignancy Potential of Porokeratosis: A Single-Center Retrospective Study.汗孔角化症的恶性潜能:一项单中心回顾性研究。
Cureus. 2021 Feb 2;13(2):e13083. doi: 10.7759/cureus.13083.
8
Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer.细胞周期蛋白D1蛋白亚型在宫颈癌中的表达及其预后意义
Cancer Manag Res. 2019 Oct 24;11:9073-9083. doi: 10.2147/CMAR.S224026. eCollection 2019.
9
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.局部应用胆固醇/洛伐他汀治疗掌跖角化病:一种针对发病机制的治疗方法。
J Am Acad Dermatol. 2020 Jan;82(1):123-131. doi: 10.1016/j.jaad.2019.08.043. Epub 2019 Aug 23.
10
Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes.在 MVD 或 MVK 突变杂合子中,具有体细胞重组或 C>T 转换的二次打击细胞的克隆扩增形成汗孔角化病。
J Invest Dermatol. 2019 Dec;139(12):2458-2466.e9. doi: 10.1016/j.jid.2019.05.020. Epub 2019 Jun 15.